Anastomotic leak devices market to reach $4.74 billion by 2030

The global market for anastomotic leak devices is projected to grow from $3.45 billion in 2025 to $3.68 billion in 2026, according to The Business Research Company. North America held the largest share in 2025 as rising surgical volumes, minimally invasive procedures and patient-safety investments drive demand.

Why it matters: - Anastomotic leaks can cause serious post-surgical complications, including infection and sepsis, so devices that detect, prevent or manage leaks are tied directly to patient safety. - The market is expanding as hospitals and surgeons look for tools that support better recovery outcomes and fewer complications after gastrointestinal and other surgeries.

What happened: - The Business Research Company released a 2026 market report on anastomotic leak devices on July 24, 2026. - The report estimates the market will rise from $3.45 billion in 2025 to $3.68 billion in 2026, a 6.8% compound annual growth rate. - The report forecasts the market will reach $4.74 billion by 2030, growing at a 6.5% compound annual growth rate. - North America held the largest share of the market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Anastomotic leak devices are used at surgical connection points between hollow organs, such as sections of the intestine, after gastrointestinal surgery. - The category includes leak detection sensors, sealing materials, drainage mechanisms and stents. - The devices are designed to identify, prevent or manage leaks and help maintain the integrity of the anastomosis while tissue heals. - The market’s recent growth is linked to limited availability of specialized leak detection tools, heavy reliance on conventional surgical methods, more gastrointestinal and cardiovascular surgeries, growing awareness of post-operative complications and wider use of single-use surgical instruments. - Future growth is expected to come from advanced reusable and disposable prevention devices, integration with smart surgical systems, more hospital spending on patient-safety technology, stronger demand for minimally invasive surgery and expansion of specialty surgical clinics. - Key trends include growing preference for disposable surgical devices, incorporation of leak detection sensors into surgical protocols, wider use of minimally invasive techniques and a continued push to reduce post-surgical complications. - The report says surgical volume is a major demand driver for the category. - A PubMed dataset cited in the release showed an average of 877 surgeries per 100,000 people in the U.S. in May 2023, with cesarean sections at 30.1%, hernia repairs at 16.4% and laparotomies at 5.1%. - The release says surgical volumes tend to rise with higher GDP per capita. - The company’s 2026 reports also include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future-trend graphics.

Between the lines: - The report points to a market shaped by both clinical need and workflow change, with disposable devices and smart-surgery integration emerging as the clearest commercial themes. - North America’s leading position suggests the category is already more established in higher-spending healthcare systems, while the inclusion of multiple global regions signals room for broader international adoption.

What's next: - Demand is expected to track growth in minimally invasive and gastrointestinal procedures as hospitals continue investing in patient-safety technologies. - The market’s next phase likely depends on how quickly reusable, disposable and sensor-enabled devices move from development into routine surgical use. - Download a free sample of the report - Read the full market report

The bottom line: - Anastomotic leak devices are moving from a niche surgical support category toward broader adoption as surgery volumes rise and providers prioritize complication reduction.